FLT3 mutants promote cancer cell proliferation and suppress the programmed cell death pathway of apoptosis through an overactivation of the above-named pro-proliferative signaling pathways and JAK/STAT5 signaling [1, 2]. The gene discussed is FLT3; the disease is cancer.